Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD52 (clone YTH34I.5L-G2Eb). We employs the Lentivirus (pBAD-Cy3-IL-4-XbaI) vector components and the SynExpress system of the Exons Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Rat
Target
CD52
Clone
YTH34I.5L-G2Eb
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
pBAD
Effector Gene
IL-4
Insertion Sites
XbaI
Gene Modification
Knockout
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.92
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.